oseltamivir has been researched along with Bacterial Disease in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 6 (75.00) | 24.3611 |
2020's | 2 (25.00) | 2.80 |
Authors | Studies |
---|---|
Hayat Khan, A; Ishaqui, A; Khan, I; Sulaiman, SAS; Taher Alsultan, M | 1 |
Alsultan, M; Ishaqui, AA; Khan, AH; Khan, I; Syed Sulaiman, SA | 1 |
Norris, A; Sandrock, CE | 1 |
Heikkinen, T | 1 |
Campins, A; Carratalà, J; Fariñas, MC; Gudiol, F; López-Medrano, F; Martínez-Montauti, J; Moreno, A; Oteo, JA; Pachón, J; Paño-Pardo, JR; Rodríguez-Baño, J; Segura, F; Torre-Cisneros, J; Viasus, D; Villoslada, A | 1 |
Koay, ES; Lee, HK; Lin, C; Quak, SH; Suhaila, M; Tambyah, PA; Tang, JW; Yap, HK | 1 |
Cho, B; Kang, YA; Kim, HS; Kim, JH; Kim, JS; Lee, HG; Lee, JK; Shin, SY | 1 |
McCullers, JA | 1 |
2 review(s) available for oseltamivir and Bacterial Disease
Article | Year |
---|---|
Infection in severe asthma exacerbations and critical asthma syndrome.
Topics: Animals; Asthma; Azithromycin; Bacterial Infections; Ceftriaxone; Coinfection; Critical Illness; Disease Progression; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Oseltamivir; Seasons; Syndrome | 2015 |
Preventing and treating secondary bacterial infections with antiviral agents.
Topics: Animals; Antiviral Agents; Bacterial Infections; Child, Preschool; Disease Models, Animal; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Mice; Oseltamivir; Pneumonia, Bacterial; Randomized Controlled Trials as Topic; Treatment Outcome | 2011 |
6 other study(ies) available for oseltamivir and Bacterial Disease
Article | Year |
---|---|
Comparative efficacy assessment of antiviral alone and antiviral-antibiotic combination in prevention of influenza-B infection associated complications.
Topics: Adult; Aged; Anti-Bacterial Agents; Antiviral Agents; Bacterial Infections; Drug Therapy, Combination; Female; Hospitalization; Humans; Influenza B virus; Influenza, Human; Length of Stay; Male; Middle Aged; Oseltamivir; Retrospective Studies; Treatment Outcome | 2021 |
Assessment of Antiviral combination therapy with Cephalosporin antibiotic for prevention of severe Influenza-A (H1N1)pdm09 infection associated secondary bacterial infection and other complications.
Topics: Antiviral Agents; Bacterial Infections; Cephalosporins; Cohort Studies; Coinfection; Drug Therapy, Combination; Female; Hospitalization; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Middle Aged; Oseltamivir | 2020 |
Respiratory viruses and children.
Topics: Antiviral Agents; Bacterial Infections; Child; Child, Preschool; Cost of Illness; Humans; Influenza, Human; Oseltamivir; Otitis Media; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Viral Vaccines; Virus Diseases | 2016 |
Factors associated with severe disease in hospitalized adults with pandemic (H1N1) 2009 in Spain.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Bacterial Infections; Disease Outbreaks; Female; Hospitalization; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Intensive Care Units; Male; Middle Aged; Obesity; Oseltamivir; Pandemics; Pneumonia; Prospective Studies; Risk Factors; Severity of Illness Index; Spain; Treatment Outcome | 2011 |
Mixtures of oseltamivir-sensitive and -resistant pandemic influenza A/H1N1/2009 viruses in immunocompromised hospitalized children.
Topics: Antiviral Agents; Bacterial Infections; Child; Child, Hospitalized; Child, Preschool; Drug Resistance, Viral; Genetic Variation; Humans; Immunocompromised Host; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Oseltamivir | 2011 |
Fatal cases of 2009 pandemic influenza A (H1N1) in Korea.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Bacterial Infections; Child; Child, Preschool; Female; Humans; Infant; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Middle Aged; Oseltamivir; Pandemics; Republic of Korea | 2011 |